Bharat Biotech's Covaxin Shows 81% Efficacy In Phase 3 Trials Conducted On 25k Subjects

Bharat Biotech's Covaxin Shows 81% Efficacy In Phase 3 Trials Conducted On 25k SubjectsПодробнее

‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial resultsПодробнее

Bharat Biotech’s Covaxin shows 81% efficacy in Phase 3 Clinical trialsПодробнее

Bharat Biotech Announces Phase 3 Results of Covaxin, Says It Shows Interim Efficacy of 81%| BreakingПодробнее

81% Interim Clinical Efficacy For Bharat Biotech’s Made-In-India COVID-19 Vaccine, CovaxinПодробнее

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacyПодробнее

editorji newswrap: Bharat Biotech: Covaxin showed 81% efficacy in phase 3 trialsПодробнее

Covaxin Shows 77% Efficacy In Phase 3 Trials, Bharat Biotech Informs Govt Panel, Data Under ReviewПодробнее

Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat BiotechПодробнее

Covaxin Phase 3 Interim Trial Data: Results Show 81% Efficacy Rate, Claims Bharat BiotechПодробнее

Covaxin's interim clinical efficacy is 81%Подробнее

BHARAT BIOTECH GETS NOD FROM DCGI PANEL FOR PHASE III TRIALSПодробнее

Bharat Biotech releases Covaxin Phase-3 trial data, claims 77.8% efficacy - TV9Подробнее

Bharat Biotech Phase 3 Results | Covaxin releases their interim analysis from phase three trialsПодробнее

Bharat Biotech Covaxin shows 81% efficacy after second dose in phase 3 trialsПодробнее

Covaxin Shows 81 Percent Efficacy In Phase 3 Clinical Trial | Bharat BiotechПодробнее

Phase III Trials Of Bharat Biotech's Covaxin | CNBC-TV18Подробнее

‘COVAXIN’ demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat BiotechПодробнее

77.8% efficacy of covaxin in phase 3 trial - Bharat biotechПодробнее

Bharat Biotech Concludes Phase 3 trial Of Covaxin Records 77.8% Efficacy RateПодробнее